Osteoclastogenic capacity of peripheral blood mononuclear cells is not different between women with and without osteoporosis.
暂无分享,去创建一个
M. Zillikens | J. V. van Leeuwen | B. V. D. van der Eerden | M. van Driel | R. Alves | W. Koek | M. Schreuders-koedam | B. C. van der Eerden
[1] O. Franco,et al. The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.
[2] S. Dong,et al. DC‐STAMP, the Key Fusion‐Mediating Molecule in Osteoclastogenesis , 2014, Journal of cellular physiology.
[3] S. Gordon,et al. In Vitro Generation of Mature Human Osteoclasts , 2011, Calcified Tissue International.
[4] Xu Feng,et al. Disorders of bone remodeling. , 2011, Annual review of pathology.
[5] L. Melton,et al. The Unitary Model for Estrogen Deficiency and the Pathogenesis of Osteoporosis: Is a Revision Needed? , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] P. Gerdhem,et al. Bone turnover markers and prediction of fracture: A prospective follow‐up study of 1040 elderly women for a mean of 9 years , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] Qingxia Zhao,et al. Cathepsin K: a therapeutic target for bone diseases. , 2009, Biochemical and biophysical research communications.
[8] M. Eijken,et al. Evidence for multiple peroxisome proliferator‐activated receptor γ transcripts in bone: Fine‐tuning by hormonal regulation and mRNA stability , 2008, FEBS letters.
[9] A. Hofman,et al. The RIZ Pro704 insertion-deletion polymorphism, bone mineral density and fracture risk: the Rotterdam study. , 2008, Bone.
[10] P. Bernabei,et al. Risedronate Reduces Osteoclast Precursors and Cytokine Production in Postmenopausal Osteoporotic Women , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] Monique M. B. Breteler,et al. The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.
[12] S. Cummings,et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. , 2006, JAMA.
[13] A. Uitterlinden,et al. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] G. Pescarmona,et al. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] R. Cumming,et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. , 2004, The Journal of clinical endocrinology and metabolism.
[16] M. Brown,et al. Osteoclast formation from circulating precursors in osteoporosis , 2003, Scandinavian journal of rheumatology.
[17] A. Hofman,et al. The Incidence of Vertebral Fractures in Men and Women: The Rotterdam Study , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] B. Dawson-Hughes,et al. Secondary hyperparathyroidism and bone turnover in elderly blacks and whites. , 2001, The Journal of clinical endocrinology and metabolism.
[19] J. de Dios Luna,et al. Relation Between Vitamin D Insufficiency, Bone Density, and Bone Metabolism in Healthy Postmenopausal Women , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] P. Delmas,et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] A. Hofman,et al. Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study , 1996, BMJ.
[22] T. Martin,et al. Structural and functional correlations in parathyroid hormone responsive transplantable osteogenic sarcomas. , 1979, European journal of cancer.
[23] Ankita Agrawal,et al. Human osteoclast culture and phenotypic characterization. , 2012, Methods in molecular biology.
[24] L. Melton,et al. Involutional osteoporosis. , 1986, The New England journal of medicine.